La Jolla Submits Riquent Application For Lupus In EU
The company is still pursuing a Phase III trial in the U.S. under a Special Protocol Assessment with FDA.
The company is still pursuing a Phase III trial in the U.S. under a Special Protocol Assessment with FDA.